Breast implant illness
From Wikipedia, the free encyclopedia
| Breast implant illness | |
|---|---|
| Other names | Autoimmune/autoinflammatory syndrome induced by adjuvants |
| Specialty | Gynecology, toxicology |
| Symptoms | Arthralgia, chronic fatigue, cognitive dysfunction, dryness of the eyes, dryness of the mouth, myalgia, pyrexia[1] |
| Causes | Aggravation of underlying autoimmune diseases caused by silicone breast implants[1] |
| Risk factors | Family or personal history of allergies or autoimmune diseases[1] |
Breast implant illness (BII), also known as autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA), along with other terms, is a condition that affects certain women with breast implants, with symptoms Its acceptance as a legitimate disease is controversial,[2][3] but meta-analyses consistently underscore that "women with implants tend to have increases in symptoms and diagnoses compared to similar women in the general population,"[4] and that this particularly but not exclusively affects those with underlying allergies or autoimmune diseases.[1] Nonetheless, it remains poorly defined, and its existence has still not been conclusively proven.[3][5] The idea of BII has existed since the 1960s,[2] but it has more recently been popularized on social media.[5] There are currently no diagnostic criteria nor specific diagnostic tests, thus BII is considered to be a diagnosis of exclusion.[6][7]